Gene Therapy
- Ref-No.Technology
- 01-00987
DMD Gene Therapy Approach
- 01-01015
AAV-based split-dCas9 gene activator system for in vivo reprogramming approaches
- 03-00553
Human TCR constructs for adoptive cell therapy of cancer
- 15-00446
Liver stem cell generation for therapeutic applications
- 32-00076
Next generation allogeneic CAR-NK cell platform for treatment of malignant diseases
- 32-00082
Reprogramming immune cells to develop allogenic CAR cell-based therapies
- 32-00083
CRISPR-Cas induced immunosuppressant resistance in anti-viral T cell products for clinical application
- 32-00101
High-level recombinant adeno-associated virus production
- 32-00164
The CXCR3alt-CXCL11 chemokine system for therapeutic use in solid cancer
- 40-00003
BreakTag - Novel method for detection of ds-breaks and analysis of CRISPR-induced on- and off-target effects